Cargando…

Both Optimal Matching and Procedure Duration Influence Survival of Patients after Unrelated Donor Hematopoietic Stem Cell Transplantation

Eighty-six patients suffering from hematological malignancies, immunodeficiencies, and aplastic anemias received alloHSCT from unrelated donors. Donors were selected from the BMDW files and further matching was performed according to the confirmatory typing procedure with the use of PCR SSP and that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizia, Sylwia, Dera-Joachimiak, Dorota, Polak, Malgorzata, Koscinska, Katarzyna, Sedzimirska, Mariola, Lange, Andrzej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518791/ https://www.ncbi.nlm.nih.gov/pubmed/23243511 http://dx.doi.org/10.1155/2012/873695

Ejemplares similares

Anti-CMV-IgG Positivity of Donors Is Beneficial for alloHSCT Recipients with Respect to the Better Short-Term Immunological Recovery and High Level of CD4+CD25high Lymphocytes
por: Jaskula, Emilia, et al.
Publicado: (2015)

The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors
por: Koclega, Anna, et al.
Publicado: (2012)

Unrelated Hematopoietic Stem Cell Donor Matching Probability and Search Algorithm
por: Tiercy, J.-M.
Publicado: (2012)

The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children
por: Park, Meerim, et al.
Publicado: (2011)

Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease
por: Schuetz, C., et al.
Publicado: (2008)

Autoimmune hematological diseases following haploidentical donor hematopoietic stem cell transplant compared with matched sibling and unrelated donor
por: Lv, Weiran, et al.
Publicado: (2017)

Occurrence and Impact of Minor Histocompatibility Antigens' Disparities on Outcomes of Hematopoietic Stem Cell Transplantation from HLA-Matched Sibling Donors
por: Dzierzak-Mietla, Monika, et al.
Publicado: (2012)

Modern Medical Miracle: Matched Unrelated Donor Hematopoietic Stem Cell Transplant After Aplastic Anemia
por: Van Antwerp, Emily, et al.
Publicado: (2021)

MHC Haplotype Matching for Unrelated Hematopoietic Cell Transplantation
por: Petersdorf, Effie W, et al.
Publicado: (2007)

Comparison of Matched Unrelated and Matched Related Donor Myeloablative Hematopoietic Cell Transplantation for Adults with Acute Myeloid Leukemia in First Remission
por: Walter, Roland B., et al.
Publicado: (2010)

Management of psychiatric complications in unrelated donor before unrelated peripheral hematopoietic stem cell collections
por: Hequet, Olivier, et al.
Publicado: (2016)

Matched unrelated donor hematopoietic progenitor cell transplantation: A report based on a single registry in India
por: Tiwari, Aseem K, et al.
Publicado: (2019)

Diverse Activity of IL-17(+) Cells in Chronic Skin and Mucosa Graft-Versus-Host Disease
por: Klimczak, Aleksandra, et al.
Publicado: (2019)

IFNL4 and donor selection for matched unrelated donor haematopoietic stem-cell transplantation
por: Westervelt, Peter
Publicado: (2020)

Human Leucocyte Antigen System and Selection of Unrelated Hematopoietic Stem Cell Donors: Impact of Patient–Donor (Mis)matching and New Challenges with the Current Technologies
por: Crocchiolo, Roberto, et al.
Publicado: (2023)

The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
por: Lange, Andrzej, et al.
Publicado: (2018)

Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow
por: Lange, Andrzej, et al.
Publicado: (2018)

The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety
por: Parmar, Gaganvir, et al.
Publicado: (2023)

Support of Unrelated Stem Cell Donor Searches by Donor Center-Initiated HLA Typing of Potentially Matching Donors
por: Schmidt, Alexander H., et al.
Publicado: (2011)

Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type
por: Mehta, Rohtesh S., et al.
Publicado: (2023)

Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia
por: Sheikh, Irtiza N., et al.
Publicado: (2022)

Biosimilar G-CSF versus filgrastim and lenograstim in healthy unrelated volunteer hematopoietic stem cell donors
por: Farhan, Roiya, et al.
Publicado: (2017)

The Benefits of the Post-Transplant Cyclophosphamide in Both Haploidentical and Mismatched Unrelated Donor Setting in Allogeneic Stem Cells Transplantation
por: Dybko, Jarosław, et al.
Publicado: (2023)

Deposition of callose in young ovules of two Taraxacum species varying in the mode of reproduction
por: Musiał, Krystyna, et al.
Publicado: (2014)

A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants
por: Jardine, Laura, et al.
Publicado: (2015)

Determination of an unrelated donor pool size for human leukocyte antigen-matched platelets in Brazil
por: Bub, Carolina Bonet, et al.
Publicado: (2016)

Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation
por: Williams, Louis, et al.
Publicado: (2020)

Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders
por: Woolfrey, Ann, et al.
Publicado: (2018)

Novel genetic variants associated with mortality after unrelated donor allogeneic hematopoietic cell transplantation
por: Hahn, Theresa, et al.
Publicado: (2021)

The World Marrow Donor Association: Twenty Years of International Collaboration for the Support of Unrelated Donor and Cord Blood Hematopoietic Cell Transplantation
por: Petersdorf, Effie W.
Publicado: (2010)

Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study
por: Ruggeri, Annalisa, et al.
Publicado: (2016)

Recruiting unrelated donors for the National Marrow Donor Program.
por: Yanke, D. R.
Publicado: (1990)

Alpha/Beta T-Cell Depleted Grafts as an Immunological Booster to Treat Graft Failure after Hematopoietic Stem Cell Transplantation with HLA-Matched Related and Unrelated Donors
por: Rådestad, E., et al.
Publicado: (2014)

Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis
por: Tie, Ruxiu, et al.
Publicado: (2017)

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR
por: Dehn, Jason, et al.
Publicado: (2019)

Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?
por: Fernandez-Sojo, Jesus, et al.
Publicado: (2021)

P1581: DYNAMICS OF NT-PROBNP LEVEL IN UNRELATED DONORS DURING MOBILIZATION OF HEMATOPOIETIC STEM CELLS
por: Minaeva, Natalia, et al.
Publicado: (2023)

HLA-DRB3/4/5 Matching Improves Outcome of Unrelated Hematopoietic Stem Cell Transplantation
por: Tsamadou, Chrysanthi, et al.
Publicado: (2021)

Donor-derived mycosis fungoides following reduced intensity haematopoietic stem cell transplantation from a matched unrelated donor
por: Kinsella, Francesca A M, et al.
Publicado: (2017)

Antithymocyte globulin improves the survival of patients with myelodysplastic syndrome undergoing HLA-matched unrelated donor and haplo-identical donor transplants
por: Wang, Hong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q5si2in46toqlu0b9vrsid4o2m